Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Charlotte Guldborg Nyvold"'
Publikováno v:
MethodsX, Vol 12, Iss , Pp 102741- (2024)
We present a lightweight tool for clonotyping and measurable residual disease (MRD) assessment in monoclonal lymphoproliferative disorders. It is a translational method that enables computational detection of rearranged immunoglobulin heavy chain gen
Externí odkaz:
https://doaj.org/article/aeef8d2617064c849d68e20e7a76d3db
Autor:
Marcus Hansen, Oriane Cédile, Marie L.G. Kjeldsen, Mads Thomassen, Birgitte Preiss, Niels Abildgaard, Charlotte Guldborg Nyvold
Publikováno v:
HemaSphere, Vol 7, p e46173a3 (2023)
Externí odkaz:
https://doaj.org/article/4b26a2b6622f42e2a7f02bf3223ca55c
Autor:
Simone Valentin Hansen, Mia Koldby Blum, Marcus Høy Hansen, Oriane Cédile, Jacob Haaber, Niels Abildgaard, Charlotte Guldborg Nyvold
Publikováno v:
HemaSphere, Vol 7, p e25523df (2023)
Externí odkaz:
https://doaj.org/article/759003b8f5d7406fb813bea8d5bf6aaf
Autor:
Oriane Cédile, Sólja Remisdóttir Veyhe, Marcus Høy Hansen, Kjell Titlestad, Charlotte Guldborg Nyvold
Publikováno v:
BioTechniques, Vol 71, Iss 5, Pp 550-555 (2021)
Externí odkaz:
https://doaj.org/article/db2af8d95ab5413eb8434e08292b8000
Autor:
Simone Valentin Hansen, Marcus Høy Hansen, Oriane Cédile, Michael Boe Møller, Jacob Haaber, Niels Abildgaard, Charlotte Guldborg Nyvold
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Mantle cell lymphoma (MCL) is a malignancy arising from naive B lymphocytes with common bone marrow (BM) involvement. Although t(11;14) is a primary event in MCL development, the highly diverse molecular etiology and causal genomic events ar
Externí odkaz:
https://doaj.org/article/fcfd47c3dcaf495b817c3a62de0ec18d
Autor:
Lea Amalia Lind Elkjær, Oriane Cédile, Marcus Høy Hansen, Christian Nielsen, Michael Boe Møller, Niels Abildgaard, Jacob Haaber, Charlotte Guldborg Nyvold
Publikováno v:
Leukemia Research Reports, Vol 18, Iss , Pp 100341- (2022)
High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) has become a treatment option for fit patients with mantle cell lymphoma (MCL). However, these patients often relapse within few years, potentially caused by contaminating
Externí odkaz:
https://doaj.org/article/dc4fc79cca87400aa0e9852c2fc1e725
Publikováno v:
Data in Brief, Vol 38, Iss , Pp 107349- (2021)
Next-generation sequencing (NGS) of whole genomes has become more accessible to biomedical researchers as the sequencing price continues to drop, and more laboratories have NGS facilities or have access to a core facility. However, the rapid and robu
Externí odkaz:
https://doaj.org/article/37250ef840b34d189f092908fa8cba4c
Autor:
Dianna Hussmann, Anna Starnawska, Louise Kristensen, Iben Daugaard, Astrid Thomsen, Tina E. Kjeldsen, Christine Søholm Hansen, Jonas Bybjerg-Grauholm, Karina Dalsgaard Johansen, Maja Ludvigsen, Thomas Kristensen, Thomas Stauffer Larsen, Michael Boe Møller, Charlotte Guldborg Nyvold, Lise Lotte Hansen, Tomasz K. Wojdacz
Publikováno v:
Haematologica, Vol 107, Iss 4 (2021)
Currently, no molecular biomarker indices are used in standard care to make treatment decisions at diagnosis of chronic lymphocytic leukemia (CLL). We used Infinium MethylationEPIC array data from diagnostic blood samples of 114 CLL patients and deve
Externí odkaz:
https://doaj.org/article/c610eee3b3c743b6b035337410c7a22b
Autor:
Marcus Høy Hansen, Karen Juul-Jensen, Oriane Cédile, Stephanie Kavan, Michael Boe Møller, Jacob Haaber, Charlotte Guldborg Nyvold
Publikováno v:
Leukemia Research Reports, Vol 15, Iss , Pp 100255- (2021)
Relapse involving the central nervous system (CNS) is an infrequent event in the progression of mantle cell lymphoma (MCL) with an incidence of approximately four percent. We report four cases of MCL with CNS relapse. In three of the four patients a
Externí odkaz:
https://doaj.org/article/8bbdef5b300245b2a15a3362716c5b28
Autor:
Marcus Celik Hansen, Line Nederby, Anne Roug, Palle Villesen, Eigil Kjeldsen, Charlotte Guldborg Nyvold, Peter Hokland
Publikováno v:
MethodsX, Vol 2, Iss C, Pp 145-153 (2015)
Sequencing the exome is quickly becoming the preferred method for discovering disease-inducing mutations. While obtaining data sets is a straightforward procedure, the subsequent analysis and interpretation of the data is a limiting step for clinical
Externí odkaz:
https://doaj.org/article/5316969cb95147378e0dc20890aeed15